ETD system

Electronic theses and dissertations repository


Tesi etd-11162016-095615

Thesis type
Tesi di laurea specialistica LC6
Mieloma multiplo: confronto tra la PET-CT e le tecniche di imaging convenzionali
Corso di studi
relatore Prof. Petrini, Mario
tutor Dott.ssa Galimberti, Sara
Parole chiave
  • 18F-fluorodeoxyglucose positron emission tomograph
  • planar radiographs
  • computed tomography
  • magnetic resonance imaging
  • bone disease
  • multiple myeloma
Data inizio appello
Data di rilascio
Riassunto analitico
Multiple myeloma: a comparison between PET-CT and conventional imaging <br><br>Background<br>Multiple myeloma(MM) is a plasma cell neoplasia that represents one of the most frequent hematological malignancies.<br>Bone lesions are one of the CRAB criteria used to diagnose a symptomatic MM, fundamental for starting the treatment.<br>Several imaging techniques are used today to point out a bone involvement at the diagnosis and during the follow up: PET-CT is a whole body nuclear medicine imaging able to discriminate bone involvement thanks to its high sensitivity. Nevertheless, the international guidelines still don’t clearly establish that PET-CT as the gold standard technique for assessment the bone involvement and which one would be the best is still a matter of debate.<br><br>Objectives<br>With these premises, our single-centre retrospective trial was designed to compare PET-CT with conventional imaging methods (X-ray, CT, MRI) at the diagnosis and during the follow-up. Finally, we assessed a possible predictive and prognostic role of PET-CT in terms of quality or response and survival.<br><br>Patients and Methods<br>We prospectively compared 18F-FDG PET-CT with planar radiographs, CT and MRI in a series of 160 patients with diagnosed symptomatic (N=149) or smouldering multiple myeloma (SMM)(N=11).<br>Our patients with MM received a first line treatment with or without autologous hematopoietic stem cell transplantation according their age and co-morbidities.<br>Therapeutic regimens used for transplant induction or for first line treatment was essentially based on combinations containing Bortezomib, Thalidomide(± Melphalan) or Doxorubicin.<br>Bortezomib, lenalidomide, and melphalan were the drugs more frequently employed in patients not eligible to transplantation.<br><br><br><br>Results<br>We calculated for each technique sensitivity and specificity: at diagnosis, PET-CT was really superior to planar radiographs, showing a sensitivity of 75% (vs 56,25% for X-rays). <br>PET-CT was also superior to CT, showing sensitivity values of 100% (vs 66,66% for CT).<br>In contrast, both PET and MRI showed sensitivity values equal to 100%.<br>Similarly to what was observed at diagnosis, PET CT during follow-up showed distinct advantages in terms of sensitivity compared to X-rays (83,15% vs 60,65%, respectively).<br>In contrast, only a little difference between PET-CT and CT was detected during treatment (76,36% vs 75%, respectively).<br>On the contrary, differently from what we observed at diagnosis, a little difference in terms of sensitivity was shown in favor of MRI compared to PET CT(88,68% for MRI vs 83,93% for PET-CT). <br>Overall, PET CT sensitivity was significantly higher than the X-Rays sensitivity (82,18% vs 60,14%, respectively).<br>A little difference was observed between PET-CT and CT in terms of sensitivity (78,69 % vs 73,85 %, respectively).<br>No differences were observed between PET-CT and MRI(sensitivity: 90,32%).<br><br>Conclusions<br>PET-CT and MRI have an equivalent overall sensitivity in the assessment of bone involvement in patients with multiple myeloma.<br>It’s especially true at the diagnosis, where we recommend performing PET-CT for its high sensitivity and its whole-body character, supplemented by spine and pelvis MRI in presence of clinical symptoms in these areas.<br>During follow-up, the MRI seems to represent a good tool; however, PET-CT also provides a viable alternative, especially in the absence of clinical involvement of the spine and pelvis areas.<br>